Most Popular Stories
- Healthy Choices: Nine Healthcare Bloggers Worth a Click
- More uninsured likely as COBRA subsidy expires
- Medical travel outside U.S. falls substantially
- Cleveland Clinic backs company selling searchable patient data
- Five Fierce Female Healthcare Bloggers to Watch
- HHS to award $80 million for HIT workforce training
Featured Jobs
-
Pediatrician Job in California
StaffPointe, LLC - near San Francisco, CA -
RN Manager of Inpatient Rehab
MRI of St Petersburg - St. Petersburg, FL -
Family Practitioner Job in Indiana
StaffPointe, LLC - northwest, IN -
Occupational Therapist
Makro Health - Manassas, VA -
Family Nurse Practitioner
Makro Health - Grundy
Events
- Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - Harvard Business School 7th Healthcare Conference
January 30, 2010
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
Press Release: Cardiovascular Drugs, Four Other Therapeutic Classes of Drugs Dominate the Market
Cardiovascular Drugs, Four Other Therapeutic Classes of Drugs Dominate the Market
ROCKVILLE, Md., Jan. 24, 2007 -- In 2004, American adults spent $32 billion on cardiovascular drugs, putting them at the top of the five costliest classes of drugs prescribed by doctors for people age 18 and over, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The five costliest classes of drugs combined accounted for two thirds – $119 billion – of the $181 billion total expenditures spent on outpatient prescription medications by adults in the United States in 2004.
Hormones were the second-costliest drug class ($25 billion), followed by central nervous system drugs ($24 billion), which can be used to treat pain and control seizures; cholesterol-lowering medications ($22 billion); and anti-depressants and other psychotherapeutic drugs ($18 billion).
Among adults who had a prescription drug purchase in 2004, the highest percentage purchased at least one central nervous system drug (44 percent), followed by cardiovascular medications (38 percent), hormones (37 percent), anti-cholesterol drugs (22 percent), and antidepressants (20 percent).
AHRQ also looked at spending for the top five therapeutic classes of drugs prescribed for Medicare beneficiaries age 65 and older in 2004.
The top five classes were cardiovascular drugs ($17 billion), cholesterol-lowering drugs ($10 billion), hormones ($8 billion), central nervous system drugs ($7 billion), and gastrointestinal drugs ($6 billion). Spending totaled nearly $48 billion.
Expenditures for these drugs accounted for roughly three-quarters of the $65 billion spent on all prescription drugs for Medicare beneficiaries age 65 and older in 2004.
AHRQ, a part of the U.S. Department of Health and Human Services, works to improve the quality, safety, efficiency and effectiveness of health care in the United States. The data in this AHRQ News and Numbers comes from the Agency’s Medical Expenditure Panel Survey, a highly detailed source of information on the health services that Americans use, how frequently they use them, the cost of these services, and how they are paid.
For more information on this AHRQ News and Numbers please see the attachment.
For more information or to speak with an AHRQ data expert, contact Bob.Isquith@ahrq.hhs.gov or call (301) 427-1539.
Related Stories
- U.S. spends almost $1B annually on blood thinners
- Grassley: CMS ignored repeated Medicare fraud warnings
- Mental health coverage still not equal
- Study: Long hospital shifts boost mistakes
- Study:Primary care costs, reimbursement low
- L.A. groups plan for emergency pharma distribution
- GAO: HHS agencies need to collaborate to fight HAIs
- Comparative effectiveness research becomes battleground
- Committee makes comparative-effectiveness spending recommendations
- Case study: Michigan hospitals, Johns Hopkins reduce ICU infections
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





